Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2016 · second_quarter · Q2
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Source: Senate LDA
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Bipartisan Budget Act of 2015
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Bipartisan Budget Act of 2015
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Consolidated Appropriations Act, 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Consolidated Appropriations Act, 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Patient-Focused Impact Assessment Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Patient-Focused Impact Assessment Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Advancing Hope Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Advancing Hope Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Advancing Targeted Therapies for Rare Diseases Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Advancing Targeted Therapies for Rare Diseases Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
FDA and NIH Workforce Authorities Modernization Act
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
FDA and NIH Workforce Authorities Modernization Act
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Advancing Precision Medicine Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Advancing Precision Medicine Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Promoting Biomedical Research and Public Health for Patients Act
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
Promoting Biomedical Research and Public Health for Patients Act
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 -- Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025; S. Con. Res. 11 -- An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025; public health and emerging infectious disease preparedness and response.
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H.R. 83 - Consolidated and Future Continuing Appropriations Act of 2015 H. Con. Res. 27 - House Budget Resolution S. Con. Res. 11 - Senate Budget Resolution Public health and emerging infectious disease preparedness and response.
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 83 - Consolidated and Future Continuing Appropriations Act, 2015
Bipartisan Budget Act of 2015
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Consolidated Appropriations Act, 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures Act Senate "Innovation For Healthier Americans" initiative S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures Act Senate "Innovation For Healthier Americans" initiative S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response; 21st Century Cures Initiative. H.R. 6 - 21st Century Cures Act
H.R. 83 - Consolidated and Future Continuing Appropriations Act of 2015 H. Con. Res. 27 - House Budget Resolution S. Con. Res. 11 - Senate Budget Resolution Public health and emerging infectious disease preparedness and response.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 83 - Consolidated and Future Continuing Appropriations Act, 2015
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
Advancing Targeted Therapies for Rare Diseases Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures Act Senate "Innovation For Healthier Americans" initiative S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015
Advancing Targeted Therapies for Rare Diseases Act of 2016
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures Act Senate "Innovation For Healthier Americans" initiative S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015
Fair Access to Science and Technology Research Act of 2015
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
Fair Access to Science and Technology Research Act of 2015
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
Fair Access to Science and Technology Research Act of 2015
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 -- Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025; S. Con. Res. 11 -- An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025; public health and emerging infectious disease preparedness and response.
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 83 - Consolidated and Future Continuing Appropriations Act, 2015
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: SAREPTA THERAPEUTICS, INC. · Firm: SAREPTA THERAPEUTICS, INC.
H.R. 83 - Consolidated and Future Continuing Appropriations Act of 2015 H. Con. Res. 27 - House Budget Resolution S. Con. Res. 11 - Senate Budget Resolution Public health and emerging infectious disease preparedness and response.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2016 · first_quarter · Q1
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2015 · fourth_quarter · Q4
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures Act Senate "Innovation For Healthier Americans" initiative S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2015 · third_quarter · Q3
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 83 - Consolidated and Future Continuing Appropriations Act, 2015
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures Act Senate "Innovation For Healthier Americans" initiative S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2015 · second_quarter · Q2
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response; 21st Century Cures Initiative. H.R. 6 - 21st Century Cures Act
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
H.R. 83 - Consolidated and Future Continuing Appropriations Act of 2015 H. Con. Res. 27 - House Budget Resolution S. Con. Res. 11 - Senate Budget Resolution Public health and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2015 · first_quarter · Q1
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response; 21st Century Cures Initiative.
H. Con. Res. 27 -- Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025; S. Con. Res. 11 -- An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025; public health and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2014 · fourth_quarter · 4A
Consolidated and Further Continuing Appropriations Act of 2015 (H.R. 83); Public health and emerging infectious disease preparedness and response.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response; 21st Century Cures Initiative.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2014 · fourth_quarter · Q4
Consolidated and Further Continuing Appropriations Act of 2015 (H.R. 83); Public health and emerging infectious disease preparedness and response.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response; 21st Century Cures Initiative.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS, INC. via SAREPTA THERAPEUTICS, INC.
2014 · fourth_quarter · RR
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response.
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response.